Immunotherapy in inflammatory bowel disease: Novel and emerging treatments

Inflammatory bowel disease (IBD) is a chronic disabling inflammatory process that affects young individuals, with growing incidence. The etiopathogenesis of IBD remains poorly understood. A combination of genetic and environmental factors triggers an inadequate immune response against the commensal...

Descripción completa

Detalles Bibliográficos
Autores principales: Catalan-Serra, Ignacio, Brenna, Øystein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314405/
https://www.ncbi.nlm.nih.gov/pubmed/29624476
http://dx.doi.org/10.1080/21645515.2018.1461297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314405/
https://www.ncbi.nlm.nih.gov/pubmed/29624476
http://dx.doi.org/10.1080/21645515.2018.1461297

Ejemplares similares